• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$27.96 $2.16 (8.37%)

REAL-TIME: Last trade at

Amylin Pharmaceuticals, Inc.

NASDAQ:AMLN

Vanguard Made Major Buys In These High Growth Healthcare And Tech Stocks In Q1

Lilly's GLP-1 Agonist Delivers - Analyst Blog

What These Winning Investments Can Teach You

Revenues Skyrocket at Merged Alkermes - Analyst Blog

Company News for May 16, 2012 - Corporate Summary

3 Stocks Near 52-Week Highs Worth Selling

This Biotech's for Sale! Reportedly.

1 Biotech Maximizing Shareholder Value

1 Big Pharma Restocking Its Pipeline

1 Dividend to Buy, 1 Dividend to Sell

When Will Spectrum's Run End?

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO

Whoa! The Dow's Got Nothing on These 2 Stocks

Come On, Amylin, Just a Little Clue?

Do Apple earnings augur a tech comeback?

Amylin Gets Carl Icahn Off Its Neck! (AMLN, IEP)

Icahn: Suit Against Amylin Dropped After Talks With CEO

Buy, Sell, or Hold: Avanir Pharmaceuticals

Warning: Good Biotechs Get Acquired; the Rest Don't

Monday’s biggest gaining and declining stocks

Ardea Biosciences and Sirius XM Radio Among Most Active Stocks in Pre-Market Today

U.S. futures tumble on China, Europe pressure

Pre-Market Most Active for Apr 23, 2012 : BAC, RDEA, SNY, TOT, SIRI, NOK, ERIC, WMT, AMLN, RDS/A, Q

Why Amylin Shares Popped

24/7 Wall St. Closing Bell (GE, FFIV, GRPN, PGR, REGN, CHKP, COP, DHI, ETN, HAS, PCH, XRX, AMLN, LSI

3 Biotechs Posting Big Moves

Amylin, Ardea Biosciences Show Brisk Pace for Biotech Drug Deals

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

FDA Is Asked To Remove Novo Nordisk Diabetes Drug From Market

UPDATE: FDA Is Asked To Remove Novo Nordisk Diabetes Drug From Market

Stocks Shaking the Investment World

Will Bristol-Myers Squibb Help You Retire Rich?

This Billionaire Is Wasting Your Money

Amylin Completes BLA Submission - Analyst Blog

Are These 2 Biotechs About to Be Bought?

Media Digest (4/5/2012) Reuters, WSJ, NYT, FT, Bloomberg

Medical Stocks: 75% of Americans to Be Obese by 2020

UPDATE: Icahn Tells Amylin To Pursue Sale, Seeks Proxy Extension

2nd UPDATE: Icahn Tells Amylin To Pursue Sale, Seeks Proxy Extension

Surprise! Carl Icahn Has Opinion About This Biotech Sale Rumor

See More Articles...